Deutsche Bank Maintains Buy on Wendy’s, Raises Price Target to $24
Deutsche Bank analyst Brian Mullan maintains Wendy's (NASDAQ:WEN) with a Buy and raises the price target from $20 to $24.
Deutsche Bank Maintains Buy on ON Semiconductor, Lowers Price Target to $65
Deutsche Bank analyst Ross Seymore maintains ON Semiconductor (NASDAQ:ON) with a Buy and lowers the price target from $70 to $65.
Deutsche Bank Maintains Buy on MaxLinear, Lowers Price Target to $45
Deutsche Bank analyst Ross Seymore maintains MaxLinear (NASDAQ:MXL) with a Buy and lowers the price target from $55 to $45.
Deutsche Bank Maintains Buy on Marvell Tech, Lowers Price Target to $65
Deutsche Bank analyst Ross Seymore maintains Marvell Tech (NASDAQ:MRVL) with a Buy and lowers the price target from $75 to $65.
MKM Partners Assumes Centennial Resource Dev at Buy, Announces Price Target of $10
MKM Partners analyst Leo Mariani assumes Centennial Resource Dev (NASDAQ:CDEV) with a Buy rating and announces Price Target of $10.
Morgan Stanley Maintains Overweight on Lockheed Martin, Lowers Price Target to $522
Morgan Stanley analyst Kristine Liwag maintains Lockheed Martin (NYSE:LMT) with a Overweight and lowers the price target from $525 to $522.
Morgan Stanley Maintains Equal-Weight on Hess Midstream, Lowers Price Target to $34
Morgan Stanley analyst Robert Kad maintains Hess Midstream (NYSE:HESM) with a Equal-Weight and lowers the price target from $35 to $34.
Morgan Stanley Maintains Overweight on Republic Services, Raises Price Target to $147
Morgan Stanley analyst Toni Kaplan maintains Republic Services (NYSE:RSG) with a Overweight and raises the price target from $142 to $147.
Barclays Maintains Overweight on Citizens Financial Group, Lowers Price Target to $54
Barclays analyst Jason Goldberg maintains Citizens Financial Group (NYSE:CFG) with a Overweight and lowers the price target from $62 to $54.
Morgan Stanley Maintains Overweight on Five Below, Lowers Price Target to $140
Morgan Stanley analyst Simeon Gutman maintains Five Below (NASDAQ:FIVE) with a Overweight and lowers the price target from $150 to $140.